EGFR and non-small cell lung carcinoma: In addition, a previous study showed that knockdown of CMTM7 promotes the malignant potential of non-small cell lung cancer cells and activates the epidermal growth factor receptor/protein kinase B (EGFR/AKT) signaling pathway by decreasing EGFR internalization and degradation (Liu 2015).